Evidence map›Paper›PMID 36457706›Full record

ReviewFrontiers in pharmacology2022

Global perspectives on

Jasmine M Olvany, Scott M Williams, Peter A Zimmerman

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Differential impact of Tafenoquine and Primaquine onAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Association ofPathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jasmine M OlvanyThe Center for Global Health and Diseases, Pathology Department, Case Western Reserve University, Cleveland, OH, United States.
Scott M WilliamsDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Peter A ZimmermanThe Center for Global Health and Diseases, Pathology Department, Case Western Reserve University, Cleveland, OH, United States.
Case Western Reserve University · USCenter for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical trial and individual patient treatment outcomes have produced accumulating evidence that effective primaquine (PQ) treatment of

Indexed as

activity scoreCYP2D6hypnozoitemalariaprimaquine

Identifiers

PMID36457706
PMCPMC9705595
OpenAlexW4309109380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.